Search results
Immunotherapy for stomach cancer: Types and effectiveness
Medical News Today· 4 days agoImmunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in...
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks via Yahoo Finance· 4 days agoEarlier in the month, BMY announced that a late-stage study seeking to expand the label of Opdivo in...
Regeneron faces new biosimilar threats; an AI biotech lays off staff
BioPharma Dive via Yahoo Finance· 5 days agoThey’re also starting a preclinical cancer immunotherapy program. OSE will receive €13.5 million...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 3 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 3 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 7 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
FDA sets new review date for Halozyme's drug delivery tech By Investing.com
Investing.com· 5 days agoFood and Drug Administration (FDA) has updated the Prescription Drug User Fee Act (PDUFA) goal date...
This Unpopular Dividend Stock Is a Buy
Motley Fool via Yahoo Finance· 4 days agoBMS is facing one of the steepest patent cliffs in the industry come 2028 when cancer medication Opdivo and blood thinner Eliquis could both face generic...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks via Yahoo Finance· 3 days agoIovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its...
Anavex Life Sciences Announces Expansion of Leadership Team
Morningstar· 5 days agoNEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics ...